DHAP annual report 2012 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.









Director’s Letter .................................................................................................. III
The State of the U.S. HIV Epidemic ......................................................................1
Year in Review ...................................................................................................... 5
          Supporting Prevention Programs ............................................................... 5
          Tracking the Epidemic ................................................................................. 8
          Supporting Prevention Research ............................................................... 11
          Raising Awareness ......................................................................................13
XIX International AIDS Conference ....................................................................16
FY 2012 HIV Funding at CDC ................................................................................18 
CDC HIV Resources ..............................................................................................19
DHAP Leadership ............................................................................................... 20
II
DHAP Mission and Key Areas 
DHAP’s mission is to promote health and quality of life by preventing HIV infection and reducing HIV-related 
illness and death in the United States. DHAP’s goals mirror those of the National HIV/AIDS Strategy (NHAS). 
These shared goals are aimed at decreasing the incidence of HIV, increasing access to care, improving health 




Cooperative agreements, technical 
assistance, and program and policy 
guidance for health departments, 
community-based organizations 
(CBOs), and other organizations 
working to prevent new HIV 
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HIV epidemic, risk behaviors, and 




Biomedical, behavioral, and 
operational research to develop 
new HIV prevention strategies 
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Raising Awareness
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This is an exciting time in HIV prevention. New interventions
and renewed commitment by people living with HIV and community, private sector, 
and government partners present an opportunity for real progress. In 2012, a number of 
achievements moved us closer to the Division’s goals of reducing new HIV infections, 
increasing the proportion of people who know they have HIV, improving health 
outcomes for people living with HIV, and reducing disparities. 
For example, recent information from the 20 cities participating in the National HIV 
Behavioral Surveillance System suggests that the proportion of men who have sex with 
men (MSM) with HIV who are aware of their infection increased from 56% in 2008 to 
66% in 2011. Data published in 2012 also show that the overall proportion of persons 
living with HIV who know their HIV status rose to 82% by 2009. In addition, CDC and 
health departments have been working to improve the use of CD4 and viral load data 
to improve HIV prevention and care, and the number of states with policies requiring 
the reporting of all CD4 and viral load results (including undetectable results) for 
surveillance purposes increased from 21 in 2010 to 32 in 2012.  
Programmatically, DHAP continues to pursue its high-impact approach to HIV 
prevention. In 2012, we aligned core prevention and surveillance dollars to better 
match the burden of the epidemic, maximizing the impact of prevention approaches 
nationwide. We also successfully launched campaigns encouraging HIV testing among 
African American women and MSM and campaigns that use social media to combat 
stigma and complacency.
Finally, in addition to the aforementioned successes, this year the FDA approved use of 
Truvada for pre-exposure prophylaxis (PrEP) and the over-the-counter sale of an HIV 
test. And for the first time in over 20 years, the International AIDS Conference was held 
in the United States, representing a significant victory for public health and human 
rights. 
But there is still much work to be done. Too many Americans are getting infected 
and dying from HIV every day. One in five Americans living with HIV does not know 
he or she has the virus, and only a third are receiving effective treatment that prolongs 
survival and reduces transmission to others.
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In addition, stark inequities continue to define the U.S. epidemic. In 2011, HIV diagnoses 
among African Americans accounted for an estimated 47% of all new HIV infections 
among adults and adolescents, despite representing only 12% of the U.S. population. 
Hispanics/Latinos, in 2011, accounted for 21% of new HIV infections while representing 
approximately 17% of the total U.S. population. And HIV prevalence among gay and 
bisexual men is over 40 times that of other men.
To reduce these disparities and maximize overall reductions in new HIV infections, 
prevention strategies need to be combined in the smartest and most efficient ways 
possible. CDC is implementing high impact prevention at the national level and with 
state and local partners throughout the United States to identify and implement the 
most cost-effective and scalable interventions and align them geographically and 
demographically with the HIV epidemic. High impact prevention helps maximize the 
impact of every federal prevention dollar spent to reach the goals of the National HIV/
AIDS Strategy. This report highlights prevention activities implemented by the Division 
in 2012, as well as outcomes from the surveillance and research programs that serve as 
the backbone of our efforts. 
I am grateful to, and inspired by, the commitment of the people who work in DHAP and 
those throughout the country with whom we work every day. We are closer to an AIDS-
free generation than ever before—and although our work ahead will be challenging, I 
know together we will continue to make great progress. 
Jonathan Mermin, MD, MPH
Director, Division of HIV/AIDS Prevention 
National Center for HIV/AIDS, Viral Hepatitis, 
STD and TB Prevention
Centers for Disease Control and Prevention
1
The State of the U.S. HIV Epidemic
In 2010, more than 1.1 million persons aged 13 years and older were living with an HIV 
infection in the United States, including 207,600 (18%) who were unaware of 
their infection. Over the past decade, the number of people living with 
HIV has increased while the annual number of new HIV infections has 
remained relatively stable, indicating that HIV testing, prevention, 
and treatment programs are reducing the rate of transmission. 
However, the pace of new infections continues at far too high a 
level, about 50,000 infections per year. 
In addition to the continued need for scalable, targeted 
prevention efforts, there is also a need for persons living 
with HIV to be engaged across all stages of the continuum 
of care to achieve real progress and maximize impact. For 
example, while linkage to care soon after HIV diagnosis 
is relatively high, more people living with HIV need to be 
receiving continuous care and antiretroviral treatment, and 
a greater proportion of persons infected with HIV should 
have a suppressed HIV viral load—the most important goal 
for maximizing a person’s health as well as reducing the risk of 
transmission. Continued growth in the population living with 
HIV will lead ultimately to more new infections if prevention, 
care, and treatment efforts are not intensified and improved. 
The following pages provide a snapshot of the state of the U.S. HIV 
epidemic today.
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HIV Prevalence and Incidence, 1980–2010
While the annual number of new infections remains stable, the number of Americans 
living with HIV continues to grow.
Estimates of New HIV Infections in the United States, 
2010, among Subpopulations
By transmission category, the largest number of new HIV infections currently occurs 
among men who have sex with men (MSM) of all races and ethnicities, followed by 
African American heterosexual women. By race/ethnicity overall, African Americans are 
the most heavily affected, followed by Hispanics/Latinos. 
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Estimated Rate of New HIV Infections, 2010
People of color have substantially higher rates of new HIV infection than whites due to a 
number of social, economic, and epidemiologic factors.
Estimated New HIV Infections by Route of Transmission, 2010
Two-thirds of new HIV infections occur among gay and bisexual men; however, a 
substantial proportion occur in heterosexuals and injection drugs users (IDU). 
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Percentage of HIV-infected Individuals Engaged in Selected 
Stages of Continuum of HIV Care, 2010
Treatment can help people with HIV live longer, healthier lives and also greatly reduces 
the chances of passing HIV on to others; however, only 25% of people with HIV in the 
United States are successfully keeping their virus under control.
Estimated New HIV Infections among MSM ages 13–24, 
2008–2010
The number of new infections among the youngest MSM (aged 13–24) increased 22%, 
from 7,200 infections in 2008 to 8,800 in 2010. 
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DHAP provides cooperative agreements, technical assistance, and program and 
policy guidance for health departments, CBOs, and other organizations working to 
prevent new HIV infections across the United States and its territories.
Expanding Prevention Services
The Care and Prevention in the United States (CAPUS) Demonstration Project is a 
three-year cross-agency demonstration project led by CDC to reduce HIV and AIDS-
related morbidity and mortality among racial and ethnic minorities living in the 
United States.  CAPUS represents CDC’s largest funding to date to support innovative 
demonstration projects focused specifically on reducing the clinical, social, economic, 
and structural barriers to testing, care, and treatment in communities of color. Through 
CAPUS, health departments partner with community organizations in hard-hit 
geographic areas to increase testing, linkage to and retention in care, antiretroviral 
therapy (ART) adherence, and viral suppression among racial and ethnic minorities. 
CDC has required all health departments to use surveillance data and systems at the 
clinic and individual levels in an effort to improve outcomes along the continuum of care.
CAPUS will allow CDC and its federal partners  to identify underlying factors that 
limit access and use of HIV care and prevention services in this country and to develop 
practical solutions that can reduce their impact on testing and care. Lessons learned from 
the CAPUS demonstration project will further inform how federal agencies can work 
best together as well as with health departments and communities to reach NHAS goals. 
Federal 
Partners
Office of the Assistant 
Secretary for Health (Office of 
HIV/AIDS and Infectious Disease 
Policy,	Office	of	Minority	Health,	
Office on Women’s Health), 
HRSA (both the HIV/AIDS 
Bureau and the Bureau of 
Primary Health Care), 
and	SAMHSA
CAPUS is 
supported by funds 
from the HHS Secretary’s 
Minority	AIDS	Initiative	
Fund. In FY 2012, $14.2 million 
was awarded for Year 1 activities 
beginning September 2012. The 
total projected estimated 
funding for the entire three-
year project period is 
$44.2 million. 
Eight health departments 











High Impact Prevention Through 
Health Departments
In line with goals of NHAS, DHAP is pursuing a high-
impact approach to HIV prevention—using cost-effective, 
scalable interventions with demonstrated potential to 
reduce new infections and yield the most impact on the HIV 
epidemic. CDC awarded $339 million to health departments 
nationwide to conduct core prevention activities (HIV testing, 
comprehensive prevention with HIV-positive individuals, 
condom distribution, and policy initiatives, with flexibility 
for other effective interventions) and $20 million for innovative 






Through the new health department funding 
agreement, the Missouri Department of Health 
offers the RUSH-Link program (Routine Universal 
Screening of HIV), a combination of an expanded 
testing initiative and linkage to care program. The 
goal of the program is to improve HIV-related health 
outcomes for communities of color and reduce 
health disparities through HIV peer education. In 
2012, RUSH-Link was successful in ensuring 
that 95% of its clients completed the 90-day 
linkage to care intervention, and that 
84% of the graduates were still 
in care after 12 months. 
Intensifying Testing and Linkage to Care
CDC’s MSM Testing Initiative (MTI) was developed to establish and evaluate an HIV 
testing program to identify HIV-infected MSM  who were previously unaware of their 
infection and link them to HIV medical care.  Since the program’s inception, 14 CBOs in 
11 cities across the United States have conducted approximately 9,500 tests, resulting in 
300 new diagnoses of HIV among MSM tested. 
Through MTI, CDC aims to identify at least 3,000 HIV-infected MSM who were 
previously unaware of their infection (at least  50% of those newly identified HIV-
positive men will be Hispanic/Latino or African American);  link  at least 2,550 (85%) 
of these HIV-infected MSM to HIV medical care; and write a “Best Practices” report 
based on findings from the  initiative. As a result of this 
program, it is expected that approximately 





Capacity building increases the skills, 
infrastructure, and resources of individuals, 
organizations, and communities and is a key 
strategy for improving the promotion, delivery, and 
sustainability of HIV prevention programs. During 
2012, CDC responded to 674 requests for technical 
assistance (TA) and training on topics critical to high 
impact prevention from health departments, CBOs, 
community stakeholders, and HIV prevention planning
groups. CDC also responded to 443 requests for TA and
conducted 777 training events for the HIV prevention 
workforce on topics ranging from improving 
organizational infrastructure, implementing 
effective behavioral interventions, HIV 
prevention with HIV-positive 
persons, and linkage to care.
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Intensifying Prevention Efforts for Young 
MSM of Color 
As part of its efforts to reduce HIV infections among the most affected 
populations, DHAP has awarded funding to CBOs to provide HIV tests to 
more than 90,000 young gay and bisexual men and transgender youth of color 
(YMSM TG). The YMSM TG program aims to identify more than 3,500 previously 
unrecognized HIV infections (over the five-year funding period)—and link those 
who are HIV-infected to care and prevention services. 
This program expands HIV prevention services for young gay and bisexual men of 
color, transgender youth of color, and their partners. The awards, now in their 
second year of funding, expanded upon a previous program to reach these 
populations with an increase of $10 million over five years to fund a larger 
number of community organizations. 
PARTNER PROFILE:  
AID Atlanta
Funded under DHAP’s YMSM TG program, AID Atlanta, the 
Southeast’s largest, most comprehensive AIDS Service Organization, 
targets YMSM of color and, in 2012, tested over 260 clients and 
confirmed 23 positive tests (8.7% seropositivity). AID Atlanta also 
supports the Evolution Project, an education program featuring a 
drop-in community center for young black gay men between 18 and 
28 years of age. This is a safe space that helps young black gay men 
to connect, develop strengths and skills, support each other, and 
achieve positive goals. The Evolution Project provides access to HIV 
testing and STD screening at on- and off-site locations. Members are 
provided risk counseling and linkage to free medical screenings, case 
management, HIV/STD treatment and other health care services. 
Additionally, the Evolution Project offers mental health services such 





DHAP coordinates comprehensive national surveillance systems to track the HIV 
epidemic, risk behaviors, and utilization of health care and prevention services.
Surveillance: A High-Impact Approach
Surveillance is the foundation of the nation’s HIV prevention efforts and HIV 
surveillance data provide critical information to help guide prevention programs at 
national, state, and local levels. CDC employed a new method for allocating $60 million 
in surveillance resources to better match funding with the geographic burden of HIV.  
Surveillance programs allow jurisdictions to monitor the burden and severity of HIV 
disease, and monitor the utilization of care services through the ongoing collection of 
data on laboratory test results (viral load and CD4 counts), and vital status. 
As jurisdictions improve the reporting of laboratory data to CDC, we expect estimates 
of linkage to care, retention in care, and the proportion of people with viral suppression 
to become more accurate, allowing us to more precisely monitor national progress 
toward NHAS goals.
Surveillance in the South 
In a paper published online in the Journal of Community Health, DHAP authors analyzed 
surveillance data on adults and adolescents diagnosed with HIV infection through 
December 2010 to describe the impact of HIV in the South. The authors found 
individuals in the southern states fare worse than those in other regions in HIV-related 
morbidity. 
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While many southern states have demonstrated success in HIV prevention in recent 
years, specifically decreasing the number of HIV diagnoses among women, much work 
remains. By taking a high-impact approach to both surveillance and prevention programs 
and allocating resources to better match the geographic burden of the epidemic, DHAP 
strives to improve HIV-related health outcomes in the South, as well as the rest of the 
nation.
NCHHSTP ATLAS 
Launched in January, ATLAS provides an interactive platform for accessing CDC’s 
HIV, STD , viral hepatitis, and TB surveillance data. This interactive tool provides 
CDC with an effective way to disseminate data, while allowing users to observe 
trends and patterns by creating detailed reports, maps, and other graphics. 
Surveillance data for each disease are updated annually. 
“ATLAS is great!  I 
have accessed ATLAS 
almost every day since it was 
launched. I use it to illustrate 
the issues and create charts and 
one-pagers for my colleagues.” 
—Lisa Neel,  
Indian Health Services
HIV Surveillance Systems to Monitor Viral Load
DHAP authors highlighted disparities in both access to and success of care in a paper 
published in the American Journal of Public Health. In this analysis, they found that about 
20% of people did not enter care within three months of diagnosis and about 30% of 
people living with HIV were not virally suppressed. They also observed disparities across 
race/ethnicity, age, sex, and risk groups among people who are linked to clinical care and 
virally suppressed. The paper explains how surveillance data can be used for monitoring 
progress toward NHAS goals as well as improving timely linkage to care, increasing the 
proportion of HIV-infected people who are virally suppressed. Findings conclude that 
future work must identify and address barriers to prompt the utilization of care across 
all populations for better health outcomes.
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Technical Guidance for Viral Load Calculation
CDC provided integral supplemental resources to health jurisdictions to support the 
implementation and maintenance of electronic lab reporting for all HIV-related test 
results, collect CD4 cell count and viral load data as part of core surveillance activities, 
and improve the use of geocoding to monitor and respond more precisely to local 
epidemics. CDC also released technical guidance to help HIV surveillance grantees 
and their public health partners calculate different measures of viral load, including 
community viral load (CVL).
The average viral load among all HIV-positive individuals in care in a given community 
(CVL) is correlated with the number of new infections that occur in that community.
Calculating and mapping population viral load measures can help direct prevention 
strategies and resources to where they are needed most and reduce HIV-related 
disparities. 
PARTNER PROFILE: 
Chicago Department of Health
The Chicago Department of Public Health (CDPH) has found multiple 
ways to utilize CDC’s Medical Monitoring Project (MMP) data to 
complement its surveillance program and guide its programmatic 
activities and outcomes. CDPH has used MMP data to estimate the 
percentage of people living with HIV who are on ART and virally 
suppressed and to calculate Chicago’s current continuum of care. 
Local questions regarding initiation of care, reasons for discontinuity 
in care, and provider practices for appointment reminders and lost 
appointments have increased CDPH’s understanding of potential 
points of intervention to improve linkage to and retention in care. 
This information has been shared with Chicago’s local integrated 
prevention and care housing planning council and has helped in the 





DHAP supports biomedical, behavioral, and operational research to develop new 
HIV prevention strategies and improve existing programs.
PrEP Biomedical Research and Interim Guidance
CDC published results of the TDF2 study, which found that a once-daily oral dose 
of HIV antiretroviral drugs (pre-exposure prophylaxis (PrEP)) reduced the risk 
of acquiring HIV infection by 62% overall in the study population of uninfected 
heterosexually active men and women. Blood-level data showed that participants who 
became infected had far less drug in their blood, compared with matched participants 
who remained uninfected, suggesting that medication adherence is associated with the 
efficacy of PrEP in preventing HIV infection.
These data, along with those from other PrEP studies, represented a crucial step toward 
better understanding the ways in which antiretroviral drugs may be used to help stop 
the spread of HIV. CDC published interim PrEP implementation guidance for providers 
for use with heterosexually active adults. Last year, CDC published interim PrEP 
guidance for providers for use with MSM.   
Complementary Tools—Surveillance and Research
By using two complementary epidemiologic approaches—each addressing the 
limitations of the other—CDC can provide a more complete and accurate assessment 
of the health status and clinical outcomes of people living with HIV. The Medical 
Monitoring Project (MMP) and HIV Outpatient Study (HOPS) are two examples of 
such approaches. 
MMP is the most comprehensive project of its kind, providing 
information about the behaviors, medical care, and health status of 
people living with HIV/AIDS. The project has been implemented 
across 23 areas and is designed to produce nationally representative 
data on people living with HIV/AIDS who are receiving HIV medical 
care in the United States. HOPS is a study conducted by CDC since 
1993 that allows for greater ability to assess trends over time and to 
evaluate associations between treatment and clinical outcomes, such 
as survival. Data collected and information provided by MMP and 
HOPS are often used together to inform planning activities and to 
help estimate resource needs for treatment and services for HIV-
positive persons. 
For example, CDC surveillance data continue to show the disproportionate burden of 
HIV among African Americans and Hispanics/Latinos.  However, as demonstrated by 
an analysis of data published from HOPS, survival among patients prescribed ART and 
responding well to treatment differed not by race/ethnicity but by the source of payment 
for medical care: publically insured patients were significantly more likely to die than 
those who were privately insured. HIV care for most HIV-infected Americans is paid for 
by public sources. 
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As reported by MMP, over 65% of patients in care pay for their medication using 
either Medicare/Medicaid or the AIDS Drug Assistance Program (ADAP). Additional 
evaluation of the HOPS data indicated that the burden of comorbid diseases, such as 
cardiovascular and renal disease, both in life and as causes of death, were significantly 
greater among publicly insured patients. This implies that the difference in survival 
noted in HOPS was not related to the quality of care publicly insured patients received 
but rather by the greater burden of preventable disease they experience. With patients 
living longer, these kinds of preventable conditions will increasingly become the focus of 
HIV care.
High-Impact Approaches for High-Prevalence Cities 
DHAP released a report on promising practices based on the Enhanced Comprehensive 
HIV Prevention Planning (ECHPP) project’s grantee experiences. Under ECHPP, 
demonstration projects in 12 heavily HIV-affected cities representing 44% of the 
total U.S. AIDS cases were funded to implement a mix of HIV prevention approaches 
likely to have the greatest impact within their areas. Lessons learned from ECHPP 
have informed how CDC could work better with health departments, other U.S. 
government agencies, and communities to reach the NHAS goals across the country. 
ECHPP 
Cities 








Philadelphia’s AIDS Activity Coordinating Office 
Philadelphia’s AIDS Activity Coordinating Office provided data to DHAP for 
a new HIV prevention resource allocation tool to help prioritize the funding 
of high impact HIV prevention interventions by health departments. 
DHAP’s resource allocation model projects the expected number of new 
HIV cases over one to five years and indicates the best allocation of an HIV 
prevention budget for each program and population to prevent the most 
new HIV cases. Through ECHPP, Philadelphia used the results of this model 
to inform its HIV prevention funding decisions, spending more to test MSM 
in non-clinical settings, and more on behavioral risk reduction programs 
for HIV-infected persons, particularly MSM. It spent less on behavioral risk 
reduction programs for the uninfected and high-risk heterosexuals. CDC is 
currently working with federal and non-federal partners to adapt this tool 
and develop technical assistance so health departments can use the tool 





DHAP develops communications campaigns and partnerships to ensure that all 
people know the facts about HIV, are aware of their status, and understand how to 
protect themselves.
Take Charge. Take the Test. 
Take Charge. Take the Test.™ was launched in March 2012 in 10 major U.S. cities where 
large numbers of African American women are affected by HIV.  This public education 
campaign encourages HIV testing and awareness among African American women, who 
are more severely affected by HIV than women of any other race or ethnicity. Since its 
launch, there have been nearly 450 million media impressions*, and over 40,000 page 
views of the campaign Web site.
Take Charge. Take the Test. messages remind women that they have the power to take 
charge of their health and protect themselves from HIV through testing, talking openly 
with their partners about HIV, and insisting on safe sex. In each city, campaign messages 
are disseminated through radio, billboard, and transit advertising as well as community 
outreach efforts. Local health departments are leading implementation of the campaign 
in each of the participating cities, working closely with community organizations and 
venues that serve African American women. The campaign is part of CDC’s Act Against 
AIDS initiative, a five-year national communication effort that seeks to draw attention to 
the HIV epidemic in the United States. 
*A media impression is an industry standard that estimates the number of times a message has been seen 
or heard. (Note: the same person may have been exposed to the message more than once.)
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Testing and Linkage to Care Through Pharmacies
In June, CDC launched a pilot project to train pharmacists and retail store clinic staff 
at 24 rural and urban sites to deliver confidential rapid HIV testing. As of September, 
451 tests had been conducted, with 13 preliminary positives. By November, five sites had 
begun testing.
By utilizing local pharmacy and retail clinic staff, HIV testing in a pharmacy setting can 
help overcome the obstacles of distance and stigma around HIV-testing centers. In the 
United States there are approximately 60,000 community pharmacies and more than 
1,000 retail clinics. This innovative approach to increasing HIV services will expand 
HIV counseling and testing services and will conduct at least 200 HIV tests, per venue, 
annually.  
Clients with a preliminary HIV-positive result will be linked to a local health care 
provider for confirmatory testing and care. Clients will also be offered risk-reduction 
information and local referrals to assist with other health and/or social issues. In addition 
to increased testing and linkage to care, one of the expected outcomes of the project is a 
training curriculum that will serve as a toolkit for community pharmacists and staff at 
local retail clinics who plan to offer HIV testing services. 
Let’s Stop HIV Together
Another segment of CDC’s Act Against AIDS initiative, Let’s Stop HIV Together, launched 
right before the XIX International AIDS Conference, held in Washington, D.C. in July. 
Let’s Stop HIV Together is a national campaign that includes local and national advertising 
with social media to combat two major obstacles in HIV prevention—stigma associated 
with the infection and complacency about the epidemic.  Let’s Stop HIV Together features 
people living with HIV standing alongside friends and family and calling on 
all Americans to join the fight against the disease.  In addition to fighting 
stigma, Let’s Stop HIV Together combats complacency by showing that HIV 
touches every corner of American society, regardless of race, gender, or 
sexual orientation. 
Between July and December, over 10,000 campaign materials such as posters, 
palm cards, fact sheets, and Facebook cards were distributed at conferences, 
events, and to requesting organizations, as well as downloaded from the Act 
Against AIDS Web site. In this timeframe, the Facebook page has received 
almost 500 million media impressions, has more than 67,000 “likes,” and 
over 110,000 visitors. There have been more than 600,000 views of campaign 
videos on YouTube.
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To raise the visibility of Let’s Stop HIV Together, CDC negotiated  a “station 
domination” of Gallery Place Metro station in Washington, D.C. This 
strategy enabled CDC to display campaign messages on every media 
space within the station as well as strategically placed ads in high-
traffic areas. CDC shared this marketing strategy with the Kaiser 
Family Foundation’s Greater Than AIDS campaign and placed 128 
ads around the station, including dioramas, two-sheets, banners, 
platform runners, floor graphics, pillar wraps, and pylon faces. 
The campaign ran four weeks at Gallery Place and garnered more 
than 900,000 impressions. In addition to the Metro Rail, CDC 
also negotiated a station domination at the Union Station/Amtrak 
station in Washington, D.C. to reach International AIDS Conference 
attendees who use Amtrak to get to and from the city. The station 
domination included two-sheets, kiosks, banners, and floor graphic 
options. The station domination ran from July 16 to August 26, resulting 
in over 800,000 media impressions.
PARTNER PROFILE:  
Center for Black Equity
The Center for Black Equity (CBE), formally known as the International 
Federation of Black Prides, is in its third year of a five-year agreement 
with the Act Against AIDS Leadership Initiative (AAALI). Through its 
partnerships, CBE has administered more than 4,500 HIV tests in 
African American communities and its media activities have resulted in 
over 2.6 million impressions. CBE is strongly committed to supporting 
leaders, institutions, issues, and programs that lead to social, economic, 
and cultural equity for all LGBT people of African descent. With CDC, 
AAALI partners like CBE conduct communication, mobilization, and 
outreach in their communities to increase awareness of HIV and 
improve access to information and testing services. CDC launched 
AAALI as part of Act Against AIDS in 2009. The initiative brought 
together some of the nation’s foremost African American organizations 
to intensify HIV prevention efforts in black communities. In 2010, DHAP 
expanded AAALI to also include organizations that focus specifically on 
MSM and Latino communities.
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XIX International AIDS Conference 
For the first time in over 20 years, the United States hosted the XIX International AIDS 
Conference (IAC or AIDS 2012) in Washington, D.C. July 22–27th. Themed “Turning 
the Tide Together,” the conference served as a reminder that we have reached a defining 
moment in the HIV epidemic. By acting decisively on recent scientific advances in HIV 
treatment and biomedical prevention, the momentum for a cure, and the continuing 
evidence of the ability to scale-up key interventions in the most-needed settings, the 
conference emphasized that we are closer than ever to seeing an AIDS-free generation. 
AIDS 2012 brought together leading scientists, public health experts, policy-makers 
and the HIV-affected community to translate recent momentous scientific advances 
into action that will address means to end the epidemic, within the current context 
of significant global economic challenges. DHAP staff contributed to the agenda in 
meaningful ways, presenting research on key issues such as surveillance, prevention 
research, interventions, and scientific advances (PrEP, treatment as prevention, and 
testing).
To open the conference, DHAP hosted a satellite symposium on Sunday, July 22nd 
intended to familiarize audience members with the concept of high impact prevention 
in theory and in practice and to provide perspectives on implementing the strategy. 
Speakers presented perspectives from national, state and local public health department, 
and community-based organization levels. DHAP’s symposium speakers included 
Drs. Jonathan Mermin, Irene Hall, and Stephanie Sansom.
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Throughout the conference, DHAP speakers presented on various topics including:
Ū The continuum of care, which found that most Americans with HIV are not getting 
HIV treatment needed for their health and to protect the health of their partners
Ū The cost-effectiveness of more frequent HIV screening of MSM in the United States, 
which concluded that screening of MSM every three months to six months is cost-
effective and cost-saving and suggested that the screening recommendations for MSM 
should be reexamined
Ū Participant adherence in the Bangkok Tenofovir Study, an HIV pre-exposure 
prophylaxis trial among IDU in Bangkok, which suggested that the Bangkok 
Tenofovir Study will be able to provide reliable adherence data to determine if 
Tenofovir prevents HIV infection among IDU
Ū Correlates of undiagnosed HIV infection among African American women at 
increased risk of HIV, which found that social and demographic factors are stronger 
predictors of undiagnosed HIV infection among African American women than 
individual risk behaviors; and that increased testing and linkage to care and structural 
interventions are needed to address contextual factors placing African American 
women at risk for HIV
AIDS 2012 took place during a pivotal moment in our history and served as a reminder 
that intensifying HIV prevention efforts and maximizing their impact are the keys to 
ending the HIV epidemic and witnessing an AIDS-free generation.
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FY 2012 HIV Funding at CDC
In FY 2012, CDC received $786M for HIV prevention funding through the National Center for HIV/AIDS, Viral Hepatitis, 
STD, and TB Prevention. Eighty-nine percent of this funding directly or indirectly supported programs specifically 
focused on HIV, 4% supported school health-related programs, 4% supported Program Collaboration and Service 
Integration (PCSI), and 3% supported Public Health Service evaluation and other mandatory costs.
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CDC HIV Resources
CDC Division of HIV/AIDS Prevention
www.cdc.gov/HIV 




CDC’s communication campaign to refocus national attention on the HIV crisis in 
America.  The website includes information on the many targeted campaigns that  
are part of Act Against AIDS, such as Take Charge. Take the Test. for African  
American women and Let’s Stop HIV Together to combat stigma and complacency.
NCHHSTP ATLAS
http://www.cdc.gov/nchhstp/atlas/ 
The NCHHSTP ATLAS  was created to provide an interactive platform for accessing 
CDC HIV and STD data. This interactive tool provides CDC with an effective way  
to disseminate data, while allowing users to observe trends and patterns by creating  
detailed reports, maps, and other graphics.
Effective Behavioral Interventions 
www.EffectiveInterventions.org 
CDC information on accessible, evidence-based programs to promote healthy  
behaviors among those at risk for transmitting or acquiring HIV, including best 
practices and online courses.
Gay and Bisexual Men’s Health
www.cdc.gov/msmhealth 
A CDC resource for men who have sex with men, with information on how gay and 
bisexual men can protect their health through all stages of life.
National Prevention Information Network 
www.cdcnpin.org 
The U.S. reference and referral service for information on HIV/AIDS, viral hepatitis,   
sexually transmitted diseases, and tuberculosis. NPIN collects and disseminates data  
and materials to support the work of HIV/AIDS, viral hepatitis, STD, and TB  
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